These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6689330)

  • 1. Comparative analysis of the pharmacokinetic techniques available for individualizing phenytoin dosage.
    Messori A; Zaccara G; Valenza T; Arnetoli G; Bartoli C; Donati-Cori G; Muscas GC; Tendi E
    J Clin Hosp Pharm; 1983 Dec; 8(4):357-65. PubMed ID: 6689330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic approach to a dosage regimen for phenytoin based on one-point, steady-state plasma concentration.
    Nakashima E; Matsushita R; Kido H; Nakamura M; Asahi M; Ichimura F
    Ther Drug Monit; 1995 Feb; 17(1):12-8. PubMed ID: 7725371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenytoin dosage adjustment method using population clearance.
    Yukawa E; Higuchi S; Aoyama T
    Chem Pharm Bull (Tokyo); 1990 Feb; 38(2):510-2. PubMed ID: 2337967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new programmable calculator procedure for individualizing phenytoin dosage.
    Messori A; Valenza T; Zaccara G; Arnetoli G; Bartoli C; Donati-Cori G; Tendi E; Zappoli R
    Drug Intell Clin Pharm; 1983 Dec; 17(12):890-3. PubMed ID: 6653404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of four single-point phenytoin dosage prediction techniques using computer-simulated pharmacokinetic values.
    Toscano JP; Jameson JP
    Clin Pharm; 1986 May; 5(5):396-402. PubMed ID: 3720209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individualizing phenytoin dosage regimens using a programmable calculator.
    Ng PK
    Am J Hosp Pharm; 1980 Apr; 37(4):529-33. PubMed ID: 7377216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenytoin pharmacokinetic analysis and steady-state level prediction using a programmable calculator.
    Ng PK
    Int J Biomed Comput; 1980 Jul; 11(4):329-034. PubMed ID: 7399737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting individual phenytoin dosage.
    Vozeh S; Muir KT; Sheiner LB; Follath F
    J Pharmacokinet Biopharm; 1981 Apr; 9(2):131-46. PubMed ID: 7277205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical application of the Mullen and Foster method for individualizing phenytoin dosage.
    Valenza T; Messori A; Zaccara G; Arnetoli G; Bartoli C; Donati-Cori G; Muscas GC; Silvano R; Tendi E; Zappoli R
    Ital J Neurol Sci; 1984 Jun; 5(2):195-200. PubMed ID: 6469541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of a new and simple technique for individualizing phenytoin dosage.
    Yukawa E; Higuchi S; Aoyama T
    J Pharmacobiodyn; 1989 Apr; 12(4):187-92. PubMed ID: 2795428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-point feedback control method for phenytoin dosage adjustment.
    Yukawa E; Higuchi S; Aoyama T
    J Pharm Pharmacol; 1991 Jul; 43(7):499-503. PubMed ID: 1682464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of population pharmacokinetic parameters in phenytoin dosage adjustment.
    Yukawa E; Higuchi S; Aoyama T
    Chem Pharm Bull (Tokyo); 1989 Dec; 37(12):3363-6. PubMed ID: 2632085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of single-point phenytoin dosage prediction techniques.
    Yukawa E; Higuchi S; Ohtsubo K; Aoyama T
    J Clin Pharm Ther; 1988 Aug; 13(4):293-305. PubMed ID: 3235480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of six techniques for determining the Michaelis-Menten parameters relating phenytoin dose and steady-state serum concentrations.
    Mullen PW; Foster RW
    J Pharm Pharmacol; 1979 Feb; 31(2):100-4. PubMed ID: 33239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of methods for the prediction of phenytoin concentrations.
    Vázquez Rodríguez A; Santos Buelga D; Alonso González AC; Garcćia Sánchez MJ; Domínguez-Gil Hurlé A
    J Clin Pharm Ther; 1991 Feb; 16(1):55-62. PubMed ID: 2026669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical rules for phenytoin dosing.
    Privitera MD
    Ann Pharmacother; 1993 Oct; 27(10):1169-73. PubMed ID: 7818614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian regression analysis of non-steady-state phenytoin concentrations: evaluation of predictive performance.
    Killilea T; Coleman R; Ludden T; Peck CC; Rose D
    Ther Drug Monit; 1989; 11(4):455-62. PubMed ID: 2741195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New and simple method to predict dosage of drugs obeying simple Michaelis-Menten elimination kinetics and to distinguish such kinetics from simple first order and from parallel Michaelis-Menten and first order kinetics.
    Wagner JG
    Ther Drug Monit; 1985; 7(4):377-86. PubMed ID: 4082237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new approach to establishing individualized maintenance doses of phenytoin.
    Bachmann K; Sullivan TJ; Schwartz J; Jauregui L
    Ther Drug Monit; 1985; 7(4):391-400. PubMed ID: 4082238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenytoin clearances in a compliant population: description and application.
    Graves NM; Leppik IE; Termond E; Taylor JW
    Ther Drug Monit; 1986; 8(4):427-33. PubMed ID: 3824428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.